This is a multicenter, long term, open-label study of topiramate's safety in patients with inadequately controlled epilepsy. Topiramate, a drug structurally unrelated to currently available anticonvulsant drugs, may be used as single or adjunctive therapy at the discretion of the clinical investigator.
Showing the most recent 10 out of 1103 publications